Quintiles Named a “Best Place to Work in IT” by Computerworld for Fifth Time

RESEARCH TRIANGLE PARK, N.C. - Wednesday, June 19th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles (NYSE: Q) has been named to IDG’s Computerworld “100 Best Places to Work in IT” list for the fifth time.

Computerworld has recognized the top 100 companies for information technology professionals since 1994 based on criteria such as diversity, career development, training and retention.

“We are extremely honored that the Quintiles organization has been recognized by Computerworld once again,” said Quintiles Chief Information Officer Richard Thomas. “Quintiles works with leading biopharma and healthcare companies around the world, supporting them in their mission to improve health. We have been working over the years to create an environment where top technology talent has the opportunity to develop professionally and make a difference in the lives of patients around the world.”

In late 2012, Thomas was named a Computerworld “Premier IT Leader,” further indication of Quintiles’ position as the biopharma services industry’s information technology leader. Quintiles was ranked sixth in the 2012 InformationWeek 500, an annual list of the top technology innovators in the United States, evidence that great workplaces can translate to innovative products and services.

"We applaud the organizations on the Best Places to Work in IT list for creating and sustaining dynamic IT work environments," said Scot Finnie, editor in chief of Computerworld. “It's clear that the best IT workplaces are constantly raising the bar with great benefits, new learning opportunities, access to cutting-edge technologies and challenging business-critical projects."

About Quintiles

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.

Click here to subscribe to Mobile Alerts for Quintiles.

Contacts

Quintiles

Phil Bridges, Media Relations

+1-919-998-1653, +1-919-457-6347 (mobile)

phil.bridges@quintiles.com



Karl Deonanan, Investor Relations

+1-919-998-2789

InvestorRelations@quintiles.com